Winton Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-16,227
Closed -$105K 906
2023
Q4
$105K Sell
16,227
-22,610
-58% -$146K 0.01% 707
2023
Q3
$367K Buy
38,837
+21,021
+118% +$253K 0.03% 468
2023
Q2
$249K Buy
+17,816
New +$304K 0.02% 590
2021
Q4
Sell
-20,498
Closed -$442K 1474
2021
Q3
$442K Buy
20,498
+430
+2% +$10.4K 0.02% 920
2021
Q2
$515K Buy
20,068
+4,550
+29% +$97.2K 0.03% 904
2021
Q1
$283K Buy
+15,518
New +$258K 0.02% 1167
2020
Q1
Sell
-47,805
Closed -$367K 1570
2019
Q4
$367K Sell
47,805
-23,240
-33% -$136K 0.01% 1327
2019
Q3
$377K Buy
+71,045
New +$441K ﹤0.01% 1184

Other funds holding CDMO

Winton Group's CDMO Position: Q1 2024 in Review

Winton Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2024, closing a stake of 16,227 shares — an estimated $105K sold.

Winton Group first reported a position in CDMO in Q3 2019 and held it in 8 quarters. The position peaked at $515K in Q2 2021. 166 funds tracked by Wall St. Rank hold CDMO as of Q1 2024.

  • Winton Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Winton Group sold 16,227 Avid Bioservices, Inc. Common Stock shares in Q1 2024, an estimated $105K.
  • Winton Group first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2019 and held it in 8 quarters.
  • Winton Group's Avid Bioservices, Inc. Common Stock position peaked at $515K in Q2 2021.
  • 166 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2024.

Based on Winton Group's 13F filing for Q1 2024, filed 14 May 2024.